| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.083 | 0.09 |